Found: 69
Select item for more details and to access through your institution.
Curcumin Inhibits Invasiveness and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Through Reducing Matrix Metalloproteinase 2, 9 and Modulating p53-E-Cadherin Pathway.
- Published in:
- Integrative Cancer Therapies, 2015, v. 14, n. 5, p. 484, doi. 10.1177/1534735415588930
- By:
- Publication type:
- Article
Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 7, p. e278, doi. 10.1111/ijd.15468
- By:
- Publication type:
- Article
Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case–control cohort study.
- Published in:
- International Journal of Dermatology, 2021, v. 60, n. 2, p. 179, doi. 10.1111/ijd.15099
- By:
- Publication type:
- Article
Suppression of proline-directed protein kinase F.
- Published in:
- International Journal of Cancer, 2001, v. 91, n. 5, p. 665, doi. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1100>3.0.CO;2-3
- By:
- Publication type:
- Article
Nuclear p120 catenin is a component of the perichromosomal layer and coordinates sister chromatid segregation during mitosis in lung cancer cells.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-04929-z
- By:
- Publication type:
- Article
Litchi seed extract inhibits epidermal growth factor receptor signaling and growth of Two Non-small cell lung carcinoma cells.
- Published in:
- BMC Complementary & Alternative Medicine, 2017, v. 17, p. 1, doi. 10.1186/s12906-016-1541-y
- By:
- Publication type:
- Article
Longan flower proanthocyanidins induce apoptosis in HT-29 colorectal carcinoma spheroids.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 489, doi. 10.1007/s40487-021-00152-6
- By:
- Publication type:
- Article
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 474, doi. 10.3390/vaccines12050474
- By:
- Publication type:
- Article
Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1122, doi. 10.3390/vaccines9101122
- By:
- Publication type:
- Article
Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 689, doi. 10.3390/vaccines9070689
- By:
- Publication type:
- Article
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.671127
- By:
- Publication type:
- Article
Anti-Proliferation and Radiation-Sensitizing Effect of an Anthocyanidin- Rich Extract from Purple-Shoot Tea on Colon Cancer Cells.
- Published in:
- Journal of Food & Drug Analysis, 2012, v. 20, p. 328
- By:
- Publication type:
- Article
Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810661
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 15, p. 3821, doi. 10.3390/ijms20153821
- By:
- Publication type:
- Article
Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 3, p. 201, doi. 10.1159/000371735
- By:
- Publication type:
- Article
DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 1, p. 91, doi. 10.3892/ijo.2017.4021
- By:
- Publication type:
- Article
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113278
- By:
- Publication type:
- Article
Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2022, p. 1, doi. 10.1177/17534666221132731
- By:
- Publication type:
- Article
Rab11 collaborates E-cadherin to promote collective cell migration and indicates a poor prognosis in colorectal carcinoma.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 12, p. 1002, doi. 10.1111/eci.12683
- By:
- Publication type:
- Article
The Inhibitory Effect of Ellagic Acid on Cell Growth of Ovarian Carcinoma Cells.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/306705
- By:
- Publication type:
- Article
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2ndgeneration EGFR-tyrosine kinase inhibitors.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1249106
- By:
- Publication type:
- Article
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 7, p. 529, doi. 10.1111/1759-7714.15212
- By:
- Publication type:
- Article
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2548, doi. 10.1111/1759-7714.15017
- By:
- Publication type:
- Article
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 4, p. 348, doi. 10.1111/1759-7714.14674
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 12, doi. 10.1111/1759-7714.14537
- By:
- Publication type:
- Article
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 13, p. 1888, doi. 10.1111/1759-7714.14272
- By:
- Publication type:
- Article
Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 11, p. 1, doi. 10.3390/medicina57111160
- By:
- Publication type:
- Article
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Research update for articles published in EJCI in 2010.
- Published in:
- European Journal of Clinical Investigation, 2012, v. 42, n. 11, p. 1149, doi. 10.1111/eci.12001
- By:
- Publication type:
- Article
Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells.
- Published in:
- European Journal of Clinical Investigation, 2011, v. 41, n. 3, p. 277, doi. 10.1111/j.1365-2362.2010.02405.x
- By:
- Publication type:
- Article
The effect of Longan seed polyphenols on colorectal carcinoma cells.
- Published in:
- European Journal of Clinical Investigation, 2010, v. 40, n. 8, p. 713, doi. 10.1111/j.1365-2362.2010.02322.x
- By:
- Publication type:
- Article
Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1541, doi. 10.1111/1759-7714.13426
- By:
- Publication type:
- Article
Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 12, p. 2274, doi. 10.1111/1759-7714.13221
- By:
- Publication type:
- Article
Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non‐small cell lung cancer: Results of a single‐arm prospective cohort study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 8, p. 1683, doi. 10.1111/1759-7714.13125
- By:
- Publication type:
- Article
The Examinations and Literature in Tang Dynasty.
- Published in:
- Chinese Studies / Hanxue Yanjiu, 1992, v. 10, n. 1, p. 441
- By:
- Publication type:
- Article
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
- Published in:
- Environmental Health: A Global Access Science Source, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12940-024-01070-6
- By:
- Publication type:
- Article
Rab11 regulates E-cadherin expression and induces cell transformation in colorectal carcinoma.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-587
- By:
- Publication type:
- Article
Rab11 regulates E-cadherin expression and induces cell transformation in colorectal carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Induction of Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma by Litchi Seed Extract.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Induction of Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma by Litchi Seed Extract.
- Published in:
- Journal of Biomedicine & Biotechnology, 2012, v. 2012, p. 1, doi. 10.1155/2012/341479
- By:
- Publication type:
- Article
A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 351, doi. 10.1007/s00262-022-03255-9
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor Exon 19 Deletion Subtypes Do Not Influence Survival Outcomes Following First-line Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitors in Advanced Nonsmall Cell Lung Cancer Patients.
- Published in:
- Journal of Cancer Research & Practice, 2024, v. 11, n. 1, p. 28, doi. 10.4103/ejcrp.eJCRP-D-23-00043
- By:
- Publication type:
- Article
Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) Cells.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071704
- By:
- Publication type:
- Article
Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5095, doi. 10.3390/cancers14205095
- By:
- Publication type:
- Article
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 977, doi. 10.3390/cancers14040977
- By:
- Publication type:
- Article
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 316, doi. 10.3390/cancers14020316
- By:
- Publication type:
- Article
The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1361, doi. 10.3390/cancers12061361
- By:
- Publication type:
- Article
Comparison of Efficacy of 2% Chlorhexidine Gluconate–Alcohol and 10% Povidone-Iodine–Alcohol against Catheter-Related Bloodstream Infections and Bacterial Colonization at Central Venous Catheter Insertion Sites: A Prospective, Single-Center, Open-Label, Crossover Study
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2242, doi. 10.3390/jcm11082242
- By:
- Publication type:
- Article